Article info

Original research
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study

Authors

  1. Correspondence to Dr Mario Mandala; mario.mandala{at}unipg.it
View Full Text

Citation

Mandala M, Lorigan P, De Luca M, et al
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study

Publication history

  • Accepted January 6, 2021
  • First published February 16, 2021.
Online issue publication 
February 16, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.